Victoria Niklas
Director/Board Member at FIBROBIOLOGICS, INC.
Net worth: 91 350 $ as of 2024-05-30
Victoria Niklas active positions
| Companies | Position | Start | End |
|---|---|---|---|
| FIBROBIOLOGICS, INC. | Director/Board Member | 2021-04-07 | - |
| Independent Dir/Board Member | 2021-04-07 | - | |
Oak Hill Bio Corp.
 Oak Hill Bio Corp. Miscellaneous Commercial ServicesCommercial Services Oak Hill Bio, Inc. is a clinical-stage rare disease therapeutics company. It develops life-changing medicines for extremely preterm infants and patients suffering from rare autoimmune diseases. The firm has operations in the United States and United Kingdom to develop a pipeline of clinical-stage and pre-clinical investigational therapeutics acquired and licensed from Takeda Pharmaceutical Company Limited. The company is headquartered in Cambridge, MA. | Chief Tech/Sci/R&D Officer | 2021-12-31 | - |
Career history of Victoria Niklas
Former positions of Victoria Niklas
| Companies | Position | Start | End |
|---|---|---|---|
Prolacta Bioscience, Inc.
 Prolacta Bioscience, Inc. Pharmaceuticals: OtherHealth Technology Prolacta Bioscience, Inc. provides specialty formulations of human milk for the nutritional needs of premature and critically ill infants. Its products include Prolact+ H2MF, Prolact+4, Prolact+6, Prolact+8, Prolact+10 and Neo20. The company was founded by Elena Taggart Medo in1999 and is headquartered in Duarte, CA. | Chief Tech/Sci/R&D Officer | 2015-12-31 | 2018-12-31 |
UCLA Health Systems
 UCLA Health Systems Hospital/Nursing ManagementHealth Services UCLA Health Systems operates hospitals. The private company is based in Los Angeles, CA and has subsidiaries in United States. The company was founded in 1955 by Benjamin J. Ansell. John Mazziotta has been the CEO of the company since 2015. | Corporate Officer/Principal | 2013-12-31 | 2015-12-31 |
| Nemours Children's Clinic, Inc. | Corporate Officer/Principal | 2011-12-31 | 2013-12-31 |
Training of Victoria Niklas
| Harvard Medical School | Doctorate Degree |
| Harvard University | Graduate Degree |
| Goucher College | Undergraduate Degree |
Statistics
International
| United States | 8 |
| United Kingdom | 2 |
Operational
| Chief Tech/Sci/R&D Officer | 2 |
| Corporate Officer/Principal | 2 |
| Director/Board Member | 1 |
Sectoral
| Consumer Services | 4 |
| Health Technology | 3 |
| Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| FIBROBIOLOGICS, INC. | Health Technology |
| Private companies | 4 |
|---|---|
Oak Hill Bio Corp.
Oak Hill Bio Corp. Miscellaneous Commercial ServicesCommercial Services Oak Hill Bio, Inc. is a clinical-stage rare disease therapeutics company. It develops life-changing medicines for extremely preterm infants and patients suffering from rare autoimmune diseases. The firm has operations in the United States and United Kingdom to develop a pipeline of clinical-stage and pre-clinical investigational therapeutics acquired and licensed from Takeda Pharmaceutical Company Limited. The company is headquartered in Cambridge, MA. | Commercial Services |
Prolacta Bioscience, Inc.
Prolacta Bioscience, Inc. Pharmaceuticals: OtherHealth Technology Prolacta Bioscience, Inc. provides specialty formulations of human milk for the nutritional needs of premature and critically ill infants. Its products include Prolact+ H2MF, Prolact+4, Prolact+6, Prolact+8, Prolact+10 and Neo20. The company was founded by Elena Taggart Medo in1999 and is headquartered in Duarte, CA. | Health Technology |
| Nemours Children's Clinic, Inc. | |
UCLA Health Systems
UCLA Health Systems Hospital/Nursing ManagementHealth Services UCLA Health Systems operates hospitals. The private company is based in Los Angeles, CA and has subsidiaries in United States. The company was founded in 1955 by Benjamin J. Ansell. John Mazziotta has been the CEO of the company since 2015. | Health Services |
- Stock Market
- Insiders
- Victoria Niklas
- Experience
